MedTrace Logo

Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population.

NCT01817101 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2015-07-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether an omega-3 fatty acid supplementation is effective in the prevention of progressive cognitive decline in elderly people aged 75 years or older.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega-3 fatty acid supplementation

Gelatine capsule, 1 at each meals (3 per day) during one year

Sponsors & Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Joaquin Baleztena, MD · Clinica Universidad de Navarra

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2015-10-31
Completion
2015-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01817101 on ClinicalTrials.gov